Approach to Rash in a Patient with HIV

More documents

Recommendations

Info

Case 2: Patient AC• 45 yo male, new HIV diagnosis• Viral load 120,000 & CD4 320 (23%)• Started on Atripla (efavirenz,emtricitabine, tenofovir)• He calls (how many days?) and reportsa new mild red, itchy rash on chestand back• Efavirenz suspected as the cause
What would be theappropriate next step?1. Stop Atripla and consideruse of prednisone2. Change to nevirapine andTruvada (tenofovir+emtricitabine)3. Continue Atripla, , support-ive care, & monitor4. Continue Atripla and startprednisone5. Continue Atripla & initiateW/U for another etiology25% 25% 25% 25%1 2 3 4
Page 1 and 2: Approach to Rash in aPatient with H
Page 3 and 4: Discussion Topics• Causes & types
Page 5 and 6: Case 1• Put on Epzicom (abacavir/
Page 7 and 8: Skin Disorders Commonin HIV + Perso
Page 9 and 10: Cutaneous Drug Reactions:What Type
Page 11 and 12: Cutaneous Drug Reaction:Moderate Se
Page 13 and 14: Severe/Life-ThreateingCutaneous Dru
Page 15 and 16: Case 1 - Continued• Patient repor
Page 17 and 18: ARV drugs frequentlyassociated with
Page 19 and 20: Abacavir HSRFrom FDA-approved packa
Page 21 and 22: Abacavir HSR• Most signs/symptoms
Page 23 and 24: Darunavir• Rash, ~7%.• Most mil
Page 25 and 26: PhotodermatitisMaurer, TA. Topics H
Page 27 and 28: Eosinophilic FolliculitisMaurer TA
Page 29 and 30: Rashes Caused byInfections
Page 31 and 32: Secondary Syphilis
Page 33 and 34: Varicella-Zoster Virus (VZV)HIV Web
Page 35 and 36: What would be an appropriatenext st
Page 37 and 38: Cutaneous Drug Reaction:Patient Cou
Page 39: What do you recommend aboutfuture u
Page 43 and 44: Approach to EfavirenzRash• Usuall
Page 45 and 46: What would be theappropriate next s
Page 47 and 48: Patient BF
Page 49 and 50: Case 3: Continued• Seen by primar
Page 51 and 52: Patient BF’s Diagnosis:Neurosyphi
Page 53: Nevirapine Rash• More common in w

Approach to Rash in a Patient with HIV

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?